Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radar
MarketWatch, 2/7/24

Contractor for WV public employees system pays itself way more for some drugs than necessary
Ohio Capital Journal, 2/6/24

Targeting drug middlemen could create more loopholes
Bloomberg, 1/11/24

Fighting rising prescription drug costs
CBS News Detroit, 1/8/24

2024 formulary moves
Managed Healthcare Executive, 1/5/24

CVS Caremark to remove branded Humira from formularies
Formulary Watch, 1/4/24

500 drugs from over 140 brands are expected to cost more this year
PharmaNewsIntelligence, 1/3/24

With the new year comes new, higher prescription costs
Marketplace, 1/2/24

Exclusive: Drugmakers set to raise US prices on at least 500 drugs in January
Reuters, 12/29/23

Rx drug affordability crisis
New Hampshire Business Review Down to Business Podcast, 12/21/23

Insulin, PBM lawsuits seen as alternative to pricing legislation
Bloomberg Law, 12/19/23

Positive movement to rein in high prescription drug prices
Bill Meyer Show KMED, 12/13/23

CVS says it will change the way its pharmacies are paid
The New York Times, 12/5/23

Unravelling drug pricing - A conversation with Antonio Ciaccia
The PharmCast, 11/27/23

Where's the Wegovy? Weight loss medication shortage reveals pharmacy pricing pitfalls
FOX 32 Chicago, 11/13/23

3 Axis Advisors' Antonio Ciaccia talks about high out of pocket drug prices
KOA 850-AM Denver, 10/31/23

Insurance middlemen to blame for rising drug costs, Missouri pharmacy owner says
KDSK 5 On Your Side St. Louis, 10/25/23

Talking drug pricing and PBMs with Antonio Ciaccia
Scott Sloan Show, 10/25/23

Why pass-through clients of traditional PBMs lose big
SmithRx Blog, 10/17/23

Mission critical: Reform the mysterious PBM system with Antonio Ciaccia
Pharmacy Podcast Network, 10/14/2023

CVS exec: We’re going to find out if Blue Shield of California’s new drug model will lower costs
MedCity News, 10/9/23

A key American plant making antibiotics for kids risks shutting down
Bloomberg, 9/25/23

Study highlights PBMs’ role in drug prices
Managed Healthcare Executive, 9/21/23

PBMs form Transparency-Rx to push for drug pricing reform
Modern Healthcare, 9/20/23

Study: PBMs setting wildly variable prescription prices for patients at the counter, per APCI
Yahoo Finance, 9/19/23

Oregon PBM audit confirms need for reforms, say pharmacy orgs
Chain Drug Review, 8/22/23

Why Blue Shield of California is shaking up its prescription drug model
MedCity News, 8/18/23

Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
Modern Healthcare, 8/17/23

Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do
STAT News, 7/26/23

Navigating supply chain dynamics & pricing disparities of biologics, biosimilars
Xtelligent Healthcare Media, 7/11/23

Expert weighs in on why drug prices continue to climb
KMVT Twin Falls, 6/26/23

New Indiana law: Drug savings passed along to consumers
Public News Service, 6/20/23

Drugmakers restricting 340B pharmacy sales threaten PBMs profits
Modern Healthcare, 6/9/23

Merck suit poised to send Biden drug price law to Supreme Court
Bloomberg Law, 6/7/23

Podcast: Rage against the machine: Pharmacy benefit managers
Rxperience Podcast, 6/5/23

How to fix the national drug shortage
The New York Times, 6/2/23

Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts
STAT News, 6/1/23

Pharmacy benefit manager group decries House hearing agenda
Bloomberg Law, 5/23/23

Here’s how new laws could lower Indiana residents’ health care costs
WFYI Indianapolis, 5/22/23

US officials probe a new layer in opaque drug pricing, supply system
Bloomberg, 5/22/23

FTC orders records from Zinc Health, Ascent Health as PBM probe widens
Modern Healthcare, 5/17/23

Insurers, PBMs restrict access to weight loss drugs as demand soars
Modern Healthcare, 5/16/23

Drug wholesalers elude Congress scrutiny in pricing debate
Bloomberg Law, 5/5/23

Only one drug can treat their rare disease. but it's hard to get
Bloomberg, 5/1/23

Kratzer leaves lasting legacy
Wilmington News Journal, 4/20/23

Mark Cuban’s drug company creates a pharmacy network to challenge PBMs
STAT News, 4/18/23

Mark Cuban ventures into the world of branded drugs
Healthcare Brew, 4/13/23

Express Scripts makes price transparency move amid government scrutiny
Modern Healthcare, 4/13/23

‘Style over substance?’ Express Scripts launches new pricing plan amid rising scrutiny of PBMs
STAT News, 4/13/23

Indiana House passes bill to lower drug costs but some worry it’s too watered down to be effective
WFYI Indianapolis, 4/12/23

‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J
STAT News, 4/4/23

Drug price-sharing strategy imperiled by Ohio antitrust suit
Bloomberg Law, 3/31/23

Ohio AG Yost's lawsuit against drug middlemen 'gangsters' could have international impact
WSYX ABC 6 Columbus, 3/27/23

CDC's new opioid guidelines are too little, too late for chronic pain patients, experts say
NBC News, 3/13/23

House inquiry intensifies pressure on PBMs
Modern Healthcare, 3/6/23

Here’s how GOP lawmakers in Indiana hope to address high health care costs
WFYI Indianapolis, 1/19/23

Blues plans launch Synergie to cut costs for the priciest drugs
Modern Healthcare, 1/6/23

January’s new drug price increases take off without overcompensating for upcoming inflation-linked rebates
Endpoints News, 1/4/23

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report
Fierce Pharma, 1/4/23

Drug makers start 2023 with price hikes
Formulary Watch, 1/4/23

Pharma companies to hike cost of over 350 drugs in 2023: Analysis
NTD News, 1/2/23

Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in January
Reuters, 12/30/22

The prescription drug cost issue has not gone away
The Bend Bulletin, 12/17/22

Fixing price instability can improve access to affordable prescription drugs
STAT News, 12/15/22

New York on the verge of reining in Medicaid drug pricing dysfunction
Empire Report, 12/15/22

Mark Cuban teams with a business coalition in bid to lower drug costs for employers
STAT News, 12/8/22

Mark Cuban Cost Plus Drug partners with employer group
Modern Healthcare, 12/8/22

More Blues agree to pay for prescription digital therapies
Modern Healthcare, 11/14/22

Centene showers politicians with millions as It courts contracts and settles overbilling allegations
Kaiser Health News, 11/4/22

Pharmacists gather to report on problems with pharmacy benefit managers
Jefferson Public Radio, 11/1/22

Study: PBMs’ reimbursement puts pharmacies at risk
Formulary Watch, 11/1/22

New study: Inequity in pharmacy benefit managers’ drug pricing practices in Oregon raises serious questions
Business Wire, 10/27/22

Self-pay pharmacy in Pickerington helps customers afford generic medications
WBNS 10TV News, 10/26/22

How Ohio's new single pharmacy benefit manager will affect you
Columbus Dispatch, 10/20/22

Vertical integration podcast
Business of Pharmacy Podcast, 10/10/22

When does Medicare open enrollment take place? Here's what to know when picking your plan.
USA Today, 10/9/22

Mark Cuban’s drug company teams up with first health insurer
Modern Healthcare, 10/7/22

How will the Inflation Reduction Act impact PBM reform?
PBM Reform Podcast, 10/4/22

Kroger, Express Scripts mired in contract dispute
Modern Healthcare, 10/3/22

Legislators discuss reforming rules for pharmacy benefit managers
Richmond Register, 9/29/22

The multi-billion dollar Rx middlemen: PBMs explained
Patients Rising Podcast, 9/23/22

The high co$t of prescriptions, Part 2
Erie News Now, 9/22/22

The high co$t of prescriptions, Part 1
Erie News Now, 9/22/22

Oregon pharmacy group estimates changes coming from federal price negotiation
Jefferson Public Radio, 9/20/22

Why the price of prescription drugs is rising
WPHM-AM Paul Miller Morning Show, 9/20/22

Centene to pay $166 million to Texas in Medicaid drug pricing settlement
Kaiser Health News, 9/19/22

With new acquisition, CVS to get bigger and broader, raising concerns
Ohio Capital Journal, 9/14/22

Why 'cash' pharmacies are booming—and what it means for health care
Advisory Board, 8/24/22

Frustrated pharmacists are opting out of the insurance system, saving some customers hundreds of dollars a month
The Today Show, NBC News, 8/19/22

What the Inflation Reduction Act means for PBMs
Modern Healthcare, 8/18/22

Yes, U.S. insulin prices are far higher than these other countries, like viral tweets claim
Verify, 8/9/22

$300 more for the same insulin: The Medicare rule that makes pump users pay more
USA Today, 8/4/22

UnitedHealthcare to set $0 copay for insulin, other medications
Modern Healthcare, 7/15/22

Some Ohioans stocking up on Plan B pills, considering sterilization after abortion restricted
Columbus Dispatch, 7/1/22

The story behind prescription drug prices in Nevada
KDWN Talking Solutions Public Affairs Show, 6/27/22

CVS Caremark returns Eliquis to formulary after outcry
Modern Healthcare, 6/22/22

Fears ease on new pharmacy deserts in Ohio: 'The state is going to save a lot of money'
Columbus Dispatch, 6/20/22

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
STAT News, 6/16/22

Medicaid director: Despite fears, Ohio's poor and disabled won't be harmed by drug revamp
Columbus Dispatch, 6/15/22

Federal PBM probe culminates decades of M&A
Modern Healthcare, 6/14/22

Undercover: Britain's biggest GP chain
BBC Panorama, 6/13/22

FTC agrees to 'shine a light' on how drug middlemen impact your prescription prices
Columbus Dispatch, 6/8/22

The Check Up: Antonio Ciaccia of 3 Axis Advisors
Modern Healthcare, 5/16/22

Pharma expert weighs in on PBM impact on drug supply chain
Spectrum News, 5/8/22

Unlock the full potential of pharmacists with Antonio Ciaccia
Talk to Your Pharmacist Podcast, 5/1/22

California investigating Centene over alleged Medicaid fraud
Modern Healthcare, 4/25/22

Cincinnati Issues with Lincoln Ware
Star64 Cincinnati, 4/17/22

Prospect of lower fees for prescription drugs could be dashed by new maneuver from PBMs
Columbus Dispatch, 4/14/22

8 in 10 say prescription drug prices "unreasonable"
Public News Service, 4/11/22

California is investigating the corporation that took over its Medicaid drug program
Los Angeles Times, 4/7/22

US drug prices distorted to favor pharmacy benefit managers
Drug Topics, 3/22/22

Ohio attorney general investigates 'clawbacks' drug-pricing maneuver that could be illegal
Columbus Dispatch, 3/18/22

Podcast: Deserving of Better Medicare with 3 Axis Advisors
Political Pharmacist Podcast, 3/18/22

You soon might be able to visit your doctor at your local drug store
Columbus Dispatch, 3/16/22

Report: Medicare drug reforms would save seniors billions
Ohio Capital Journal, 3/10/22

This is why prescription drugs cost so much
KSL News Radio, 1/14/22

Biden administration poised to give pharmacies a major lobbying win
STAT News, 1/7/22

Proposed change in federal rules could generate 'real savings' for Medicare recipients
Columbus Dispatch, 1/7/22

Ohio launches probe of PBM practice that critics say gouges patients and taxpayers
Columbus Dispatch, 12/29/21

Podcast: Strength on a national level
Business of Pharmacy Podcast, 12/13/21

PBMs are profiting at expense of consumers and other stakeholders, group alleges
BenefitsPRO, 12/8/21

Centene hands over millions to another state as Medicaid PBM oversight rises
Modern Healthcare, 12/7/21

Pharmacy benefit managers are outwitting attempts at accountability, tougher rules
Columbus Dispatch 12/2/21

Podcast: The drug pricing middlemen driving up drug costs
National Consumers League, 12/1/21

Congressional group takes up PBMs, strikes a partisan tone
Ohio Capital Journal, 11/26/21

Making sense of the PBM scam: A conversation with Antonio Ciaccia
Conscious Pharmacist Podcast, 11/25/21

Capitol Insider: 'The PBM robbed her of hope'; pharmacy benefit managers ripped in hearing
Columbus Dispatch, 11/19/21

Future of Healthcare Summit - Tackling Costs & Pathways to Care
The Hill, 11/17/21

PBM Forum wrap up: Greater transparency, further congressional review needed to lower drug prices
House Committee on Oversight and Reform Republicans, 11/17/21

Kalderos: Study shows 340B rebates would boost hospital cash flow
Inside Health Policy, 11/12/21

Are companies still inflating the cost of Medicaid drugs?
Ohio Capital Journal, 11/4/21

Kalderos 340B rebate model improves covered entity cash flow, study by 3 Axis Advisors confirms
Kalderos blog, 11/1/21

PBM clawbacks sidestep state bans on spread pricing
Modern Healthcare, 10/29/21

A group backed by huge companies like Walmart and Boeing is fighting back against the drug-industry middlemen in trouble for overcharging customers
Business Insider, 10/28/21

Medicaid chief quietly drops bombshell: Millions obtained by PBMs unaccounted for by state
Columbus Dispatch, 10/27/21

3 Axis Advisors president / 46brooklyn Research CEO Antonio Ciaccia presentation on drug pricing distortions to the Ohio Joint Medicaid Oversight Committee
The Ohio Channel, 10/27/21

What are pharmacy benefit managers and what role do they play in the price of your prescriptions?
Cincinnati Public Radio, 10/19/21

Dispensing doctors: Should physicians sell drugs to patients?
Undark, 10/11/21

Startup PBMs' ties to legacy competitors spark transparency questions
Modern Healthcare, 10/5/21

Kansas audited its $80 million CVS prescription plan, but it's still shrouded in mystery
KCUR NPR Kansas City, 10/1/21

Coalition seeks more transparent pharmacy benefit managers
Modern Healthcare, 9/27/21

What’s Next interview with Antonio Ciaccia
WHIS News Talk, 9/23/21

KRDO’s Afternoon News interview with Antonio Ciaccia
KRDO News Radio, 9/15/21

Regionally Speaking interview with Antonio Ciaccia
Lakeshore Public Radio, 9/14/21

Bloomdaddy show interview with Antonio Ciaccia
Bloomdaddy Radio Show, 9/14/21

Rush to Reason show interview with Antonio Ciaccia
Rush to Reason via SoundCloud, 9/8/21

HB 2263 helps lower prescription drug costs in West Virginia
WDVM Washington, 9/8/21

Podcast: Uncovering $244 million in PBM spread pricing with Antonio Ciaccia
Independent Pharmacy Alliance Podcast, 8/25/21

Meet the 30 young leaders forging a new future for the healthcare industry in 2021
Business Insider, 8/16/21

When pharmacy middlemen save on medicines, why don't you save money, too?
No Patient Left Behind, 7/6/21

CVS wins California drug overcharge trial
Modern Healthcare, 6/24/21

DeJoy’s USPS slowdown plan will delay the mail. What’s it mean for your Zip code?
Washington Post, 6/24/21

Proposed budget changes said to threaten Medicaid reforms
Ohio Capital Journal, 6/24/21

Advocates: Medicaid system overhaul could hurt behavioral health program for youth, PBM reforms
Columbus Dispatch, 6/17/21

Ohio’s overhauling $20B Medicaid program, but budget could pump the brakes
Dayton Daily News, 6/14/21

Study finds potential for billions in prescription drug savings with transparent pricing practices
PBM Reform Podcast, 5/31/21

Report says mandatory NADAC responses would save Medicaid $10B
Inside Health Policy, 5/18/21

Independent pharmacies struggle amid ‘confusing’ financial rules, study shows
Cape Cod Times, 5/14/21

Medicaid could save billions in prescription drug costs with increased survey participation
First Report Managed Care, 5/13/21

Capital Rx study: Greater price transparency around drugs could save millions in Medicaid
Fierce Healthcare, 5/12/21

Podcast: Leadership strategy implications for the changing pharmacy landscape
Leadership Lessons in Health-System Pharmacy, 5/11/21

Capital Rx and 3 Axis Advisors study finds potential for billions in prescription drug savings with transparent pricing practices
Business Wire, 5/11/21

Report: PBMs In Massachusetts make $25M annually from spread pricing
Inside Health Policy, 4/26/21

Report: Taxpayers left to pay hefty charges to MassHealth by pharmacy benefit managers
Boston Herald, 4/22/21

Pharmacists blame middlemen for high drug costs
CommonWealth Magazine, 4/22/21

Cautionary tale: Plan sponsors losing manufacturer rebate dollars to PBMs through rebate aggregators
Benefits Pro, 4/15/21

Podcast: Patients ripped off on medications
Disruptive Front Podcast, 4/12/21

New independent pharmacy opens in Huber Heights
Dayton Daily News, 4/12/21

Overworked, understaffed: Pharmacists say industry in crisis puts patient safety at risk
NBC News, 3/16/21

How to save money on medical bills by NOT using insurance
No Patient Left Behind, 3/15/21

Bills seek to save Florida Medicaid hundreds of millions of dollars, improve prescription drug care for patients
The Capitolist, 3/10/21

Small pharmacies are crucial to vaccine distribution. But it could cost them.
NBC News, 2/12/21

Adventures in getting paid
Pharmacy Today, 2/1/21

Pharmacy deserts are becoming a bigger problem in low-income neighborhoods
Axios, 1/7/21

Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
Reuters, 12/31/20

New Ohio coalition seeks to turn PBM drug-middleman profits into savings for patients
Columbus Dispatch, 12/21/20

Capitol Insider: You think you had a bad week?
Capitol Insider, 12/13/20

US Supreme Court rejects PBMs' challenge of state's ability to regulate the drug middlemen
Columbus Dispatch, 12/10/20

Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
STAT News, 12/9/20

In Florida, spread pricing costs $8.64 per pharmacy claim
Inside Health Policy, 12/9/20

We need transparent drug prices, Virginia lawmakers say
Dogwood, 11/30/20

Kettering Health patients can see prescription costs in real time with new tech
Dayton Daily News, 11/15/20

Podcast: The trouble with pharmacy benefit managers
Locked on Pharmacy Podcast, 10/22/20

Podcast: Complete and fundamental payment reform
Business of Pharmacy Podcast, 10/5/20

To beat high costs, California moves to create its own drug label
Managed Healthcare Executive, 9/30/20

Benchmark does not represent retail prices, research finds
Pharmacy Times, 9/18/20

Antonio Ciaccia highlights issues within health care, PBM operations for PCOC® 2020
American Journal of Managed Care, 9/15/20

APhA names Antonio Ciaccia Senior Advisor for Disruptive Innovation and Practice Transformation
American Pharmacists Association, 9/14/20

Drug discount programs create more cloud in quest for transparency
Informa Pharma Intelligence, 9/8/20

Study finds flaws in widely-used pricing model for generic drugs
The Pharma Letter, 7/2/20

How GoodRx built a $2.8 billion business by helping consumers find drug discounts
CNBC, 6/17/20

PBMs and community oncology: "We just can't let them get away with what they're doing"
American Journal of Managed Care, 4/25/20

PBM reimbursement significantly varies for generic drugs
Pharma News Intelligence, 4/20/20

PBM analyst Antonio Ciaccia to share drug pricing tactics, data at COA 2020
American Journal of Managed Care, 4/17/20

Pharmacy reimbursement often lags for generics undergoing price hikes, jeopardizing patient access
Pharmalot via STAT News, 4/14/20

A key ingredient that compound pharmacies need for hydroxychloroquine skyrockets in price
Pharmalot via STAT News, 4/14/20

PBM Reform Podcast series: In data we trust w/ Antonio Ciaccia
Pharmacy Podcast, 2/10/20

After acquittal, Trump repeats inaccurate claims on impeachment and Ukraine [and drug pricing]
The New York Times, 2/6/20

Florida Pharmacy Association report outlines concerns about PBM, MCO manipulations
Pharmacy Times, 2/5/20

Study finds millions in Medicaid unfairly pocketed by pharmacy benefit managers
The Capitolist, 2/4/20

PBMs favor their own pharmacies in the Florida Medicaid program
STAT News, 1/31/20

Pharmacists say they take hit in Medicaid
WUSF News, 1/31/20

NCPA: Florida report a searing indictment of PBM greed in Medicaid
National Community Pharmacists Association, 1/30/20

Pharmacy lobby releases PBM report during legislative fight
POLITICO Florida, 1/30/20

Maryland bans spread pricing following report on the practice’s cost
Inside Health Policy, 1/17/20

Washington got stuck on lowering drug prices. Now they're rising again.
Washington Post, 1/8/20

One week into 2020, drugmakers have announced nearly 450 price hikes
Advisory Board, 1/6/20

Hundreds of prescription drugs are costlier in 2020
AARP, 1/6/20

The list gets longer: Merck, Allergan, Novartis issue 2020 drug price hikes — report
Endpoints News, 1/6/20

Drug price hikes are back for 2020
Axios, 1/6/20

Two blockbuster cancer drugs see New Year price hikes
Modern Healthcare, 1/3/20

Pfizer slashes prices as most pharma makers hike prices in new year
Formulary Watch, 1/3/20

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020
Reuters, 1/3/20

Pfizer and other drugmakers start 2020 with price rises
Financial Times, 1/3/20

U.S. drug makers raise prices on more than 330 drugs
Dayton Daily News, 1/3/20

Drug companies hike prices to start the year, average 5.3 percent
The Hill, 1/2/20

Drugmakers hike 2020 medicine prices despite lawmakers’ ire
Bloomberg, 1/2/20

It’s ‘business as usual’ as many drug makers boost prices for the new year
Pharmalot via STAT News, 1/2/20

More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost
Reuters, 1/2/20

More drugmakers hike U.S. prices as new year begins
Reuters, 1/1/20

Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
Reuters, 12/31/19

Costco and Instacart test free one-hour prescription delivery as Amazon eyes the space
CNBC, 11/6/19

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar
Reuters, 10/23/19

Diabetics tell Indiana legislative committee of difficulties affording insulin
South Bend Tribune, 10/5/19

Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’
Pharmalot via STAT News, 6/5/19

Bellbrook man’s data crunching driving big pharmacy change
Dayton Daily News, 5/13/19

Report: Pharmaceutical middlemen profiting unfairly
DBusiness Magazine, 5/2/19

Medicaid managed care programs’ contracts for generic drugs are inefficient
Health Affairs, 5/1/19

Could Michigan's high drug prices flow south to Ohio?
Columbus Dispatch, 4/29/19

Pharmacists: Benefit managers taking too big a cut of payments
Crain’s Detroit Business, 4/29/19

Reports show pharmacy middlemen making big money in other states
Columbus Dispatch, 3/14/19

Drug middlemen took $123.5 million in hidden fees, state claims
Bloomberg, 2/21/19

Analysis: Prescription programs charge state more, reimburse pharmacies less for generic drugs
FiOS1 News, 1/30/19

Pharmacy benefit managers marked up generic drugs for NY Medicaid, but where’d the money go?
Pharmalot via STAT News, 1/24/19

Drug middlemen got big markup in New York, pharmacists say
Bloomberg, 1/24/19

info@3axisadvisors.com

Home

About

Projects

News

Media

Team

Contact